RGD-DA6 is an alphavbeta3-targeted ligand. RGD-DA6 consists of RGDfK (an integrin alphavbeta3-targeted RGD peptide), DOTADG, d-Glu, Lys, AMBA, and IPBA. RGD-DA6 can be radiolabeled as an alphavbeta3-targeted radioligand and used for high-contrast tumor imaging and enhanced anticancer efficacy[1].
Molecular Weight:
1796.71
CAS Number:
[3105965-82-7]
Formula:
C78H110IN17O24
Target:
Integrin
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted